| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.088 | 0.07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.079 | 0.08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.084 | 0.08 |